Scott Langille

Scott Langille has over 20 years of experience as a Chief Financial Officer in the healthcare industry. Scott is currently the Chief Financial Officer at Wayland, a position they have held since 2017. Prior to that, they were the Chief Financial Officer at Tribute Pharmaceuticals Inc. from 2007 to 2016 and at ViRexx Medical Corp. from 2006 to 2007. Scott also served as the Vice President at Biovail from 1999 to 2002. Scott has a proven track record in strategic planning, business development, investor relations, corporate financing, financial operations, and supply chain management. Scott is a highly respected leader in the healthcare industry and is committed to ensuring that Wayland remains a financially strong and successful company.

Scott Langille is a Certified Management Accountant who graduated from Ryerson University with a Bachelor of Arts. Scott then went on to obtain their Master of Business Administration from the University of Toronto.

Scott Langille works with Morten Brandt - General Manager, Europe, Geoff Kosar - Chief Commercial Officer, and Bhupinder Brar - Chief Strategy Officer. Scott Langille reports to Matt Mcleod, CEO.